| Abram Levin, MD | |
|
2000 Sutter Pl, Davis, CA 95616-6201 | |
| (530) 757-5111 | |
| Not Available |
| Full Name | Abram Levin |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 2000 Sutter Pl, Davis, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083628283 | NPI | - | NPPES |
| 00A846670 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A84667 (California) | Primary |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
New York has the first case of a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant called B.1.526, picked up by genomic surveillance research from Columbia University. The findings come after reports of other variants have been reported worldwide — B.1.1.7 in the United Kingdom, B.1.351 in South Africa, and P.1/P.2 in Brazil.
BloodCenter of Wisconsin's Diagnostic Laboratories today announced the availability of a comprehensive cancer mutation HemeOnc Panel using next generation sequencing (NGS) technology. The NGS panel developed by BloodCenter of Wisconsin is designed to detect variants in 30 genes that are either prognostic or diagnostic for 10 different myeloid hematologic malignancies.
Cepheid and Instrumentation Laboratory (IL) today announced that Cepheid has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert(R) HemosIL(R) FII & FV test.
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
In a new open access article for Cogent Social Sciences; Mobile Exercising and Tweeting the Pounds Away: The Use of Digital Applications and Microblogging and their Association with Disordered Eating and Compulsive Exercise, researchers from Georgia College & State University, and Chapman University explore the relationship between social media, eating disorders, and compulsive exercise.
› Verified 1 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
New York has the first case of a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant called B.1.526, picked up by genomic surveillance research from Columbia University. The findings come after reports of other variants have been reported worldwide — B.1.1.7 in the United Kingdom, B.1.351 in South Africa, and P.1/P.2 in Brazil.
BloodCenter of Wisconsin's Diagnostic Laboratories today announced the availability of a comprehensive cancer mutation HemeOnc Panel using next generation sequencing (NGS) technology. The NGS panel developed by BloodCenter of Wisconsin is designed to detect variants in 30 genes that are either prognostic or diagnostic for 10 different myeloid hematologic malignancies.
Cepheid and Instrumentation Laboratory (IL) today announced that Cepheid has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert(R) HemosIL(R) FII & FV test.
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
In a new open access article for Cogent Social Sciences; Mobile Exercising and Tweeting the Pounds Away: The Use of Digital Applications and Microblogging and their Association with Disordered Eating and Compulsive Exercise, researchers from Georgia College & State University, and Chapman University explore the relationship between social media, eating disorders, and compulsive exercise.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abram Levin, MD 1218 Sequoia Pl, Davis, CA 95616-2064 Ph: (530) 756-4482 | Abram Levin, MD 2000 Sutter Pl, Davis, CA 95616-6201 Ph: (530) 757-5111 |
News Archive
New York has the first case of a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant called B.1.526, picked up by genomic surveillance research from Columbia University. The findings come after reports of other variants have been reported worldwide — B.1.1.7 in the United Kingdom, B.1.351 in South Africa, and P.1/P.2 in Brazil.
BloodCenter of Wisconsin's Diagnostic Laboratories today announced the availability of a comprehensive cancer mutation HemeOnc Panel using next generation sequencing (NGS) technology. The NGS panel developed by BloodCenter of Wisconsin is designed to detect variants in 30 genes that are either prognostic or diagnostic for 10 different myeloid hematologic malignancies.
Cepheid and Instrumentation Laboratory (IL) today announced that Cepheid has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert(R) HemosIL(R) FII & FV test.
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
In a new open access article for Cogent Social Sciences; Mobile Exercising and Tweeting the Pounds Away: The Use of Digital Applications and Microblogging and their Association with Disordered Eating and Compulsive Exercise, researchers from Georgia College & State University, and Chapman University explore the relationship between social media, eating disorders, and compulsive exercise.
› Verified 1 days ago
Ryan N. Gorton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Sutter Place, Davis, CA 95616 Phone: 530-756-6440 | |
Michael Palchak, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 25133 County Road 96, Davis, CA 95616 Phone: 530-979-7775 Fax: 530-758-6904 | |
Kurt S. Kusserow, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2000 Sutter Place, Davis, CA 95616 Phone: 530-756-6440 | |
David T. Walters, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2000 Sutter Place, Davis, CA 95616 Phone: 530-756-6440 | |
Deven Babubhai Merchant, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Sutter Place, Davis, CA 95616 Phone: 530-757-5111 | |
Thomas Jeffrey Ferguson, M.D., PH.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Shields Ave, Davis, CA 95616 Phone: 530-752-2300 Fax: 530-752-2306 |